The antiviral role of nitric oxide.
Mannick
J B
JB
Department of Microbiology and Molecular Genetics and Medicine, Harvard Medical School, Boston, MA 02115, USA.
D000818:Animals; D000998:Antiviral Agents; D002478:Cells, Cultured; D004268:DNA-Binding Proteins / Q000502:physiology; D004481:Ectromelia virus / Q000254:growth & development; D004789:Enzyme Activation; D006162:Guanylate Cyclase / Q000378:metabolism; D006801:Humans; D050856:Interferon Regulatory Factor-1; D051379:Mice; D018345:Mice, Knockout; D009569:Nitric Oxide / Q000502:physiology*; D010750:Phosphoproteins / Q000502:physiology; D012264:Ribonucleotide Reductases / Q000378:metabolism; D018139:Simplexvirus / Q000254:growth & development; D014157:Transcription Factors / Q000502:physiology; D014616:Vaccinia virus / Q000254:growth & development; D014721:Vesicular stomatitis Indiana virus / Q000254:growth & development; D014777:Virus Diseases / Q000503:physiopathology*; D014779:Virus Replication
D000998:Antiviral Agents; D004268:DNA-Binding Proteins; C494257:IRF1 protein, human; D050856:Interferon Regulatory Factor-1; C494258:Irf1 protein, mouse; D010750:Phosphoproteins; D014157:Transcription Factors; D009569:Nitric Oxide; D012264:Ribonucleotide Reductases; D006162:Guanylate Cyclase